The post XRP ETFs See $6.31 Million in Daily Inflows as XRPC, GXRP, and XRPZ Excel appeared on BitcoinEthereumNews.com. TLDR XRP ETFs total daily net inflows ofThe post XRP ETFs See $6.31 Million in Daily Inflows as XRPC, GXRP, and XRPZ Excel appeared on BitcoinEthereumNews.com. TLDR XRP ETFs total daily net inflows of

XRP ETFs See $6.31 Million in Daily Inflows as XRPC, GXRP, and XRPZ Excel

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • XRP ETFs total daily net inflows of $6.31M with a cumulative net inflow of $1.23B as of February 9.
  • The XRPC ETF on NASDAQ reports a $2.31M daily inflow, holding net assets of $275.59M.
  • GXRP ETF on NYSE has daily inflows of $846.19K, with net assets of $87.44M.
  • The Franklin XRPZ ETF sees a daily inflow of $3.15M and holds $236.25M in assets.
  • TOXR and Bitwise XRP ETFs report no daily inflows or outflows, maintaining minimal changes.

According to a recent SoSoValue update as of February 9, the total daily net inflow for XRP ETFs stands at $6.31 million, with a cumulative net inflow of $1.23 billion. The total value traded on this day is recorded at $15.89 million.

XRP ETFs See Inflows Across XRPC, GXRP, and XRPZ

The XRP ETF products on various exchanges have reported varying levels of performance. A deep dive on the individual ETFs reveals that the XRPC ETF on NASDAQ, managed by Canary, shows a premium of +0.26%. The daily net inflow for this ETF amounts to $2.31 million, with a cumulative inflow of $411.16 million. It holds net assets of $275.59 million, equating to a 0.31% share of the total XRP market cap.

Source: SoSoValue (Bitcoin ETFs)

The GXRP ETF, also on the NYSE and managed by Grayscale, reports a daily inflow of $846.19K. GXRP holds the lowest net assets at $87.44 million, which represents 0.10% of XRP’s total market cap. The market price of this ETF is $28.25, with a daily change of +0.57%.

The Franklin XRPZ ETF, listed on the NYSE, has a daily inflow of $3.15 million. It currently holds $236.25 million in net assets, representing a 0.27% XRP share. Its market price stands at $15.82, with a daily increase of +0.70%.

TOXR and XRP ETFs Record No Inflow or Outflow

The TOXR ETF, trading on CBOE under the 21Shares sponsor, reports no change in daily flow with a cumulative net inflow of $70.22K. With net assets of $178.24 million, it has a minimal XRP share of 0.20%. The ETF shows a market price of $14.19, with a daily change of +0.35%.

On the NYSE, the Bitwise XRP ETF has gained a premium of +0.75%, with no changes in daily inflow and a cumulative net inflow of $357.89 million. This XRP ETF holds net assets of $263.22 million and a 0.30% XRP share. Its market price is $16.35, with a daily change of +0.74%.

The post XRP ETFs See $6.31 Million in Daily Inflows as XRPC, GXRP, and XRPZ Excel appeared first on Blockonomi.

Source: https://blockonomi.com/xrp-etfs-see-6-31-million-in-daily-inflows-as-xrpc-gxrp-and-xrpz-excel/

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.3652
$1.3652$1.3652
+0.64%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09